Torisel

In the US, Torisel (temsirolimus systemic) is a member of the drug class mTOR inhibitors and is used to treat Renal Cell Carcinoma.

US matches:

UK matches:

Ingredient matches for Torisel

Temsirolimus

Temsirolimus is reported as an ingredient of Torisel in the following countries:

  • Australia
  • Austria
  • Belgium
  • Canada
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Latvia
  • Lithuania
  • Norway
  • Philippines
  • Romania
  • Serbia
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Turkey
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)